Chronic inflammation, joint replacement and malignant lymphoma.
This paper considers the increased risk of the development of lymphoma in patients with chronic inflammatory disease who undergo metal-on-metal arthroplasty.
Lidgren
L
L
Department of Orthopaedics and Clinical Sciences, Lund University Hospital, SE-221 85 Lund, Sweden. Lars.Lidgren@med.lu.se
D019643:Arthroplasty, Replacement / Q000009:adverse effects*; D002857:Chromium / Q000506:poisoning; D002908:Chronic Disease; D003035:Cobalt / Q000506:poisoning; D003718:Denmark; D005260:Female; D005387:Finland; D000075322:Heavy Metal Poisoning; D006801:Humans; D007249:Inflammation / Q000150:complications*; D007595:Joint Prosthesis / Q000009:adverse effects*; D007960:Leukocyte Disorders / Q000139:chemically induced*; D008214:Lymphocytes / Q000737:chemistry; D008223:Lymphoma / Q000139:chemically induced*; D008297:Male; D009520:New Zealand; D018570:Risk Assessment; D013548:Sweden
D002857:Chromium; D003035:Cobalt